Prospects for cannabinoid therapies in basal ganglia disorders (PubMed)

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease:

Importance of antioxidant and cannabinoid receptor-independent properties (PubMed)

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro:

relevance to Parkinson’s disease (PubMed)

Cannabidiol can improve complex sleep-related behaviours associated with rapideye movement sleep behaviour disorder in Parkinson’s disease patients: a caseseries (PubMed)

Cannabidiol for the treatment of psychosis in Parkinson’s disease (PubMed)

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease (PubMed)

Therapeutic potential of cannabinoids in CNS disease (PubMed)

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. (PubMed 2014)

Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users (Research Gate/PubMed 2007)

Cannabidiol for the treatment of psychosis in Parkinson’s disease. (PubMed 2008)